Jump to content

Page values for "Cyclosporine"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringCyclosporine (ciclosporin)
brandStringSandimmune, Neoral (modified microemulsion, increased bioavailability), Gengraf, Restasis (ophthalmic)
structureFile
classesList of String, delimiter: ,[[:Category:Calcineurin_inhibitors|Calcineurin inhibitor]] [[:Category:Immunosuppressants|Immunosuppressant]]
mechanismString
usesString'"`UNIQ--vote-00000A8C-QINU`"', '"`UNIQ--vote-00000A8D-QINU`"', '"`UNIQ--vote-00000A8E-QINU`"', '"`UNIQ--vote-00000A8F-QINU`"', '"`UNIQ--vote-00000A90-QINU`"'
starting_doseStringTransplant: 5-10 mg/kg/d divided BID, titrated to trough levels (typically 100-300 ng/mL depending on regimen and post-transplant interval); ophthalmic Restasis 0.05% one drop BID
preparationsStringSandimmune 25, 100 mg capsules; Neoral 25, 100 mg modified soft gel; 100 mg/mL oral solution; 50 mg/mL IV; Restasis 0.05% ophthalmic emulsion
fda_maxStringTransplant: regimen-specific
pill_idText
routesList of String, delimiter: ,Oral IV ophthalmic
onsetStringDays for immunosuppressive effect
durationStringDosing-frequency dependent
halflifeString~8-27 hours (highly variable across the population)'"`UNIQ--ref-00000A91-QINU`"'
bioavailabilityStringSandimmune: highly variable (~30%); Neoral microemulsion: ~50%, less variable; '''Sandimmune and Neoral are NOT bioequivalent and not interchangeable''''"`UNIQ--ref-00000A92-QINU`"'
pregnancyStringUsed in transplant pregnancy when continued immunosuppression is required; reassuring data overall but careful monitoring needed.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US. Carries '''Boxed Warning''' for risk of malignancy and serious infection; nephrotoxicity, hypertension, and immunosuppression-associated complications'"`UNIQ--ref-00000A93-QINU`"'